The biocatalytic Friedel–Crafts acylation has
been identified
recently for the acetylation of resorcinol using activated acetic
acid esters for the synthesis of acetophenone derivatives catalyzed
by an acyltransferase. Because the wild-type enzyme is limited to
acetic and propionic derivatives as the substrate, variants were designed
to extend the substrate scope of this enzyme. By rational protein
engineering, the key residue in the active site was identified which
can be replaced to allow binding of bulkier acyl moieties. The single-point
variant F148V enabled the transformation of previously inaccessible
medium chain length alkyl and alkoxyalkyl carboxylic esters as donor
substrates with up to 99% conversion and up to >99% isolated yield.